|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| Assets: | ||||
| Deferred offering costs | ||||
| Current assets | ||||
| Cash | ||||
| Prepaid expenses | ||||
| Total current assets | ||||
| Long-term prepaid insurance | ||||
| Cash and marketable securities held in Trust Account | ||||
| TOTAL ASSETS | ||||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT | ||||
| Liabilities | ||||
| Current liabilities | ||||
| Accrued expense | ||||
| Promissory note – related party | ||||
| Accrued offering costs | ||||
| Due to Sponsor | ||||
| Total current liabilities | ||||
| Deferred underwriting fee payable | ||||
| Total Liabilities | ||||
| Class A ordinary shares subject to possible redemption, $0.001 par value; 34,500,000 shares at a redemption value of $10.20 and $10.02 per share at June 30, 2026 and December 31, 2025, respectively | ||||
| Shareholders’ Deficit | ||||
| Common stock value | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total Shareholders’ Deficit | ||||
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT |
Loading...
